CD4 and Parkinson disease: For instance, Mamula et al. [106] showed altered migration potentials of CD4+ T cells in PD patients vs controls using a multifaceted approach including transwell migration assays, as well as impaired mitochondrial positioning within the cell and reduced mitochondrial functionality.